Stay updated on Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page
- Check5 days agoChange DetectedThe page shows Revision: v3.5.4 instead of v3.5.3, representing a minor version update. This update does not modify the visible content or functionality of the page.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision label has been incremented from v3.5.2 to v3.5.3, indicating a minor technical update without changing the displayed study details.SummaryDifference0.0%

- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check63 days agoChange DetectedAn addition: Revision: v3.5.0. A deletion: Revision: v3.4.3.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check98 days agoChange DetectedAdministrative updates: v3.4.2 was added; a government funding lapse notice (and the v3.4.1 revision notice) was removed. These changes do not affect study content or user actions on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.